If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,025.00    -145.00 (-2.80%)
Bid:
5,030.00
Ask:
5,035.00
Spread: 5.00 (0.099%)
Market Cap: £18.31b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Total Voting Rights

1 Jul 2020 10:09

RNS Number : 7032R
Coca-Cola HBC AG
01 July 2020
 

Coca-Cola HBC AG

Issue of equity and total voting rights

 

Zug, Switzerland - 1 July 2020 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces in respect of the month ended 30 June 2020, the issue of 34,201 shares of CHF 6.70 each fully paid ("Ordinary Shares"), following the exercise of options granted under Coca-Cola HBC's share option plan.

 

Such Ordinary Shares were also admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities under Coca-Cola HBC's block listing facility. Following this issue, Coca-Cola HBC has the ability to admit a further 26,612,808 Ordinary Shares under its block listing facility.

 

As at 1 July 2020, Coca-Cola HBC's issued share capital consisted of 370,285,885 Ordinary Shares, of which 2,759,280 Ordinary shares are held by Coca-Cola HBC AG and 3,430,135 shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Accordingly, as at 1 July 2020, the total number of voting rights in Coca-Cola HBC is 364,096,470 for the purposes of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("DTRs").

 

Shareholders may use the above total voting rights figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Coca-Cola HBC under the DTRs.

 

This announcement is made in accordance with DTR 5.6.1.

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

Media:

David Hart

Group Communication Director

Tel: +41 41 726 0143

 david.hart@cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with 2019 revenue in excess of €7 billion. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, plant based beverages and ready-to-drink tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good, among others.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRKFLBBBDLBBBD
Date   Source Headline
18th Jan 20242:54 pmRNSDirector/PDMR Shareholding
18th Jan 20241:29 pmRNSNotice of Results
15th Jan 20244:45 pmRNSCFO stepping down to pursue new role in N. America
4th Jan 20241:45 pmRNSAthens Exchange trading date of ordinary shares
3rd Jan 202412:10 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:02 pmRNSIssue of equity and total voting rights
27th Dec 20237:15 amRNSTransaction in Own Shares
27th Dec 20237:04 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20235:35 pmRNSTransaction in Own Shares
21st Dec 20232:49 pmRNSDirector/PDMR Shareholding
20th Dec 20235:20 pmRNSTransaction in Own Shares
20th Dec 20237:15 amRNSTransaction in Own Shares
19th Dec 202312:50 pmRNSPublication of a Prospectus
19th Dec 202312:22 pmRNSDirector/PDMR Shareholding
19th Dec 20237:15 amRNSTransaction in Own Shares
15th Dec 20235:50 pmRNSTransaction in Own Shares
14th Dec 20235:45 pmRNSTransaction in Own Shares
14th Dec 20237:15 amRNSTransaction in Own Shares
13th Dec 20237:15 amRNSTransaction in Own Shares
12th Dec 20237:15 amRNSTransaction in Own Shares
11th Dec 20237:15 amRNSTransaction in Own Shares
8th Dec 20237:15 amRNSTransaction in Own Shares
7th Dec 20237:15 amRNSTransaction in Own Shares
6th Dec 20237:15 amRNSTransaction in Own Shares
5th Dec 20237:15 amRNSTransaction in Own Shares
4th Dec 20237:15 amRNSTransaction in Own Shares
1st Dec 20232:48 pmRNSDirector/PDMR Shareholding
1st Dec 20239:44 amRNSIssue of equity and total voting rights
1st Dec 20237:15 amRNSTransaction in Own Shares
30th Nov 20237:15 amRNSTransaction in Own Shares
29th Nov 20237:20 amRNSTransaction in Own Shares
28th Nov 20237:15 amRNSTransaction in Own Shares
27th Nov 20237:15 amRNSTransaction in Own Shares
24th Nov 20237:15 amRNSTransaction in Own Shares
23rd Nov 20237:15 amRNSTransaction in Own Shares
22nd Nov 202312:44 pmRNSREPLACEMENT - Transaction in Own Shares
22nd Nov 20237:15 amRNSTransaction in Own Shares
20th Nov 20234:45 pmRNSCommencement of share purchase programme
20th Nov 20234:12 pmRNSDirector/PDMR Shareholding
20th Nov 20233:29 pmRNSDirector/PDMR Shareholding
15th Nov 20233:11 pmRNSPost 2023 AGM Shareholder Engagement
9th Nov 20233:20 pmRNSDirector/PDMR Shareholding
1st Nov 20234:30 pmRNSCCH Completes the acquisition of Finlandia Vodka
1st Nov 20231:31 pmRNSBlock listing Interim Review
31st Oct 20237:00 amRNSStrong growth driving further value creation
18th Oct 20233:42 pmRNSDirector/PDMR Shareholding
5th Oct 202310:21 amRNSNotice of Results
2nd Oct 20239:23 amRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.